𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Frequent multiple hepatitis C virus infections among injection drug users in a prison setting

✍ Scribed by Son T. Pham; Rowena A. Bull; James M. Bennett; William D. Rawlinson; Gregory J. Dore; Andrew R. Lloyd; Peter A. White


Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
325 KB
Volume
52
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.

✦ Synopsis


Recent data indicate that multiple hepatitis C virus (HCV) infections (mixed infection, superinfection, and reinfection) are common among injection drug users (IDUs). In this study, we identified and characterized multiple HCV infection episodes among HCV-seronegative IDU prison inmates (n = 488) enrolled in the Hepatitis C Incidence and Transmission Study cohort. Incident HCV infection with detectable HCV RNA was identified in 87 subjects, 48 of whom completed additional follow-up to screen for reinfection or superinfection. All HCV RNA-detectable samples were tested for multiple infection through a series of specifically designed nested reverse-transcription polymerase chain reaction (nRT-PCR) with sequencing and HCV RNA level measurement. Sequencing revealed that 22 of 87 (25.3%) subjects were infected by two or more viruses. Nine (10.3%) subjects were designated as prevalent cases of incident mixed infection, because two distinct HCV strains were detected at the first viremic time point. Fifteen further cases of multiple HCV infection (superinfection or reinfection) were identified, two of which also showed baseline incident mixed infections. The incidence of new HCV infection (superinfection and reinfection) during follow-up was 40/100 person-years (95% confidence interval, 33-44/100 person-years). Spontaneous clearance of viruses from one subtype and persistence of the other subtype after mixed infection was observed in eight subjects. In these subjects, the virus with higher HCV RNA levels superseded the other.

Conclusion:

This study comprehensively analyzed frequent multiple hcv infections in a high-risk cohort and provides further insight into infection dynamics and immunity after exposure to variant viral strains. the data presented suggest that hcv rna levels play an important role in viral competition.


πŸ“œ SIMILAR VOLUMES


Molecular analysis of hepatitis C virus
✍ Massimo Ciccozzi; Gianni Zehender; Valeria Cento; Alessandra Lo Presti; Pavel Te πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 247 KB πŸ‘ 1 views

## Abstract Intravenous drug users constitute a group at risk for hepatitis C virus (HCV) infection. Today, no data are available on the molecular epidemiology of HCV in Bulgaria despite the fact that in recent years the incidence of acute hepatitis C infection among Bulgarian intravenous drug user

Hepatitis C virus infection among noninj
✍ Beryl A. Koblin; Stephanie H. Factor; Yingfeng Wu; David Vlahov πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 66 KB πŸ‘ 1 views

## Abstract The prevalence of hepatitis C virus (HCV) infection among noninjecting drug users has been reported to be higher than in the general population, but the reasons for this observation remain unclear. Noninjecting drug users aged 15–40 years and who used drugs for no longer than 10 years w

Failure to diagnose recent hepatitis C v
✍ Emma Aarons; Paul Grant; Kate Soldan; Pete Luton; Julian Tang; Richard Tedder πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 78 KB πŸ‘ 1 views

## Abstract Hepatitis C virus (HCV) infection results in chronic liver disease in a substantial proportion of those infected. Most new cases of HCV infection in the UK are associated with intravenous drug use. It is important to identify these infections because of the implications for the future h

Hepatitis C virus load and survival amon
✍ Michie Hisada; Nilanjan Chatterjee; Zeynep Kalaylioglu; Robert J. Battjes; James πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 136 KB πŸ‘ 2 views

Persons chronically infected with hepatitis C virus (HCV), some of whom may be coinfected with HIV and human T-lymphotropic virus type II (HTLV-II), are at high risk for end-stage liver disease (ESLD). We evaluated whether ESLD death was associated with premorbid HCV RNA level or specific HCV protei

Seroprevalence of hepatitis C virus and
✍ Fan-Chen Tseng; Thomas R. O'Brien; Mingdong Zhang; Alex H. Kral; Betty A. Ortiz- πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 196 KB πŸ‘ 2 views

Previous studies suggest that most injection drug users (IDUs) become infected with hepatitis C virus (HCV) and hepatitis B virus (HBV) soon after initiating drug use. The Urban Health Study (UHS) recruited serial cross-sections of IDUs in the San Francisco Bay area from 1986 to 2005. In the current

Molecular epidemiology of hepatitis C vi
✍ Yoann Morice; Jean-FranΓ§ois Cantaloube; StΓ©phanie Beaucourt; Laetitia Barbotte; πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 337 KB

## Abstract Hepatitis C virus subtype 3a (HCV‐3a) originates from Asia and has spread widely among injecting drug users as well as other patient groups in industrialized countries. HCV subtype 3a infection remains highly prevalent and frequently transmitted in the population of intravenous drug use